1 | postnatal | 3,521 |
2 | embryonic | 1,006 |
3 | larval | 462 |
4 | pubertal | 333 |
5 | preimplantation | 166 |
6 | post-natal | 156 |
7 | pre-implantation | 67 |
8 | pregnane | 55 |
9 | pupal | 38 |
10 | bcl-2-associated | 30 |
11 | 2-cell | 27 |
12 | two-cell | 27 |
13 | tadpole | 25 |
14 | third-stage | 25 |
15 | ifn-induced | 22 |
16 | peri-implantation | 21 |
17 | postpartal | 21 |
18 | 4-cell | 20 |
19 | post-hatching | 19 |
20 | eight-cell | 16 |
21 | milky | 16 |
22 | one-cell | 15 |
23 | 8-cell | 13 |
24 | postovulatory | 13 |
25 | ifn-α-induced | 12 |
26 | nymphal | 11 |
27 | day-7 | 10 |
28 | gastrula | 9 |
29 | postwithdrawal | 9 |
30 | 16-cell | 7 |
31 | postmolt | 7 |
32 | third-instar | 7 |
33 | vermiform | 7 |
34 | embryo-fetal | 6 |
35 | postembryonic | 6 |
36 | zoeal | 6 |
37 | 'postnatal | 5 |
38 | fetal-first | 5 |
39 | fruitlet | 5 |
40 | homosynaptic | 5 |
41 | post-breeding | 5 |
42 | postpacing | 5 |
43 | txp | 5 |
44 | bcl‑2‑associated | 4 |
45 | fourth-instar | 4 |
46 | peri-pubertal | 4 |
47 | post-mitotic | 4 |
48 | postentry | 4 |
49 | preleptotene | 4 |
50 | staff-assisted | 4 |
51 | treg-cell | 4 |
52 | bi-follicular | 3 |
53 | borderline/clinical | 3 |
54 | carbopack | 3 |
55 | disease-state | 3 |
56 | hip-core | 3 |
57 | mid-catch-up | 3 |
58 | mono-follicular | 3 |
59 | paranoiac | 3 |
60 | peri-adolescent | 3 |
61 | pon1-55 | 3 |
62 | sporogonic | 3 |
63 | tau-expressing | 3 |
64 | vitellogenic | 3 |
65 | 341,998 | 2 |
66 | antidepressant-resistant | 2 |
67 | anxious-somatizing | 2 |
68 | embryo/fetal | 2 |
69 | embryo/placental | 2 |
70 | end-of-semester | 2 |
71 | endotrophic | 2 |
72 | gal-1-induced | 2 |
73 | growing-furring | 2 |
74 | hamilt | 2 |
75 | hitchcock | 2 |
76 | maturating | 2 |
77 | met-min | 2 |
78 | metoestrous | 2 |
79 | middle-and-late | 2 |
80 | myomere | 2 |
81 | nauplius | 2 |
82 | nematocyte | 2 |
83 | neurula | 2 |
84 | no/transient | 2 |
85 | nonsilent | 2 |
86 | normocarbic | 2 |
87 | over-wintering | 2 |
88 | oxalate/citrate | 2 |
89 | peri-implantational | 2 |
90 | pospartum | 2 |
91 | post-diapause | 2 |
92 | pre-hemi-fontan | 2 |
93 | pre-tumor | 2 |
94 | sm22-rtta | 2 |
95 | studies- | 2 |
96 | trigeminothalamic | 2 |
97 | 'overcoming | 1 |
98 | 'retarded | 1 |
99 | /beck | 1 |
100 | /long-term | 1 |
101 | 0.06'c | 1 |
102 | 1.100-1.225 | 1 |
103 | 220.9±7.4 | 1 |
104 | 260-370 | 1 |
105 | 300-year | 1 |
106 | 31+/-2.15 | 1 |
107 | 424+/-207 | 1 |
108 | 45+/-22 | 1 |
109 | 5.29+/-2.46 | 1 |
110 | 50-word | 1 |
111 | 7.08+/-2.36 | 1 |
112 | 910529 | 1 |
113 | anxiety/or | 1 |
114 | anxietyand | 1 |
115 | apathetic-adynamic | 1 |
116 | atheroroma | 1 |
117 | atropine/breakfast | 1 |
118 | bed-rest-induced | 1 |
119 | bos-1 | 1 |
120 | broad-complex | 1 |
121 | broomrape | 1 |
122 | cadaverous | 1 |
123 | cardiomyopathies-besides | 1 |
124 | chondro-osseous | 1 |
125 | cormorbid | 1 |
126 | dbp+1/3 | 1 |
127 | drug/product | 1 |
128 | dssi/sad | 1 |
129 | ea-resisting | 1 |
130 | endogenous/melancholic | 1 |
131 | epilepsy-induced | 1 |
132 | extramembranous | 1 |
133 | ficat-arlet | 1 |
134 | follicle/oocyte | 1 |
135 | fs-driven | 1 |
136 | gender-preferential | 1 |
137 | gjb2/gjb6 | 1 |
138 | gnrh-gfp | 1 |
139 | group-operative | 1 |
140 | hepatocytescaused | 1 |
141 | hormone-modulated | 1 |
142 | ifn-alpha-induced | 1 |
143 | ifn-α-associated | 1 |
144 | il1-rn | 1 |
145 | interferon-associated | 1 |
146 | interview-defined | 1 |
147 | iodine-enriched | 1 |
148 | jointing | 1 |
149 | kory | 1 |
150 | lfcinb-mediated | 1 |
151 | lt-sensitive | 1 |
152 | malignant-related | 1 |
153 | methyl-glyoxal-mediated | 1 |
154 | midsubjective | 1 |
155 | mn0.5ni0.1zn0.4nd | 1 |
156 | moder-ate | 1 |
157 | montgomery-asperg | 1 |
158 | namg3 | 1 |
159 | neurointellectual | 1 |
160 | non-treatment-resistant | 1 |
161 | off-color | 1 |
162 | outbreeding | 1 |
163 | peadiatr | 1 |
164 | peg-ifn-α/rbv-associated | 1 |
165 | perithecia | 1 |
166 | pex-glaucoma | 1 |
167 | phytoceutical | 1 |
168 | pliance | 1 |
169 | post-hematopoietic | 1 |
170 | post-partial | 1 |
171 | postpartum/puerperal | 1 |
172 | postpenetration | 1 |
173 | postperinatal | 1 |
174 | postphacoemulsification | 1 |
175 | posturo-motor | 1 |
176 | pre-somite | 1 |
177 | pre-to-post-test | 1 |
178 | predispositional | 1 |
179 | preembryonic | 1 |
180 | purebred-crossbred | 1 |
181 | rate-of-force | 1 |
182 | rcoo | 1 |
183 | reconvalesce | 1 |
184 | saponin-supplemented | 1 |
185 | sc-ca1 | 1 |
186 | secondary-geriatric | 1 |
187 | sensory-developmental | 1 |
188 | sporangiophore | 1 |
189 | stron | 1 |
190 | sub-classifying | 1 |
191 | subhyoid | 1 |
192 | surveys.the | 1 |
193 | switch-to | 1 |
194 | taxane/platinum | 1 |
195 | techno-scientific | 1 |
196 | temporal-dependent | 1 |
197 | term-infant | 1 |
198 | tibial-head | 1 |
199 | tioso4 | 1 |
200 | treatment-resistant/chronic | 1 |
201 | triassic-arly | 1 |
202 | trophont/protomont | 1 |
203 | tumor-nude | 1 |
204 | ulcer/charcot | 1 |
205 | women-that | 1 |
206 | y=298.28-0.691 | 1 |
207 | ywhae-fam22a/b | 1 |
1 | 'overcoming | 1 |
2 | 'postnatal | 5 |
3 | 'retarded | 1 |
4 | /beck | 1 |
5 | /long-term | 1 |
6 | 0.06'c | 1 |
7 | 1.100-1.225 | 1 |
8 | 16-cell | 7 |
9 | 2-cell | 27 |
10 | 220.9±7.4 | 1 |
11 | 260-370 | 1 |
12 | 300-year | 1 |
13 | 31+/-2.15 | 1 |
14 | 341,998 | 2 |
15 | 4-cell | 20 |
16 | 424+/-207 | 1 |
17 | 45+/-22 | 1 |
18 | 5.29+/-2.46 | 1 |
19 | 50-word | 1 |
20 | 7.08+/-2.36 | 1 |
21 | 8-cell | 13 |
22 | 910529 | 1 |
23 | antidepressant-resistant | 2 |
24 | anxiety/or | 1 |
25 | anxietyand | 1 |
26 | anxious-somatizing | 2 |
27 | apathetic-adynamic | 1 |
28 | atheroroma | 1 |
29 | atropine/breakfast | 1 |
30 | bcl-2-associated | 30 |
31 | bcl‑2‑associated | 4 |
32 | bed-rest-induced | 1 |
33 | bi-follicular | 3 |
34 | borderline/clinical | 3 |
35 | bos-1 | 1 |
36 | broad-complex | 1 |
37 | broomrape | 1 |
38 | cadaverous | 1 |
39 | carbopack | 3 |
40 | cardiomyopathies-besides | 1 |
41 | chondro-osseous | 1 |
42 | cormorbid | 1 |
43 | day-7 | 10 |
44 | dbp+1/3 | 1 |
45 | disease-state | 3 |
46 | drug/product | 1 |
47 | dssi/sad | 1 |
48 | ea-resisting | 1 |
49 | eight-cell | 16 |
50 | embryo-fetal | 6 |
51 | embryo/fetal | 2 |
52 | embryo/placental | 2 |
53 | embryonic | 1,006 |
54 | end-of-semester | 2 |
55 | endogenous/melancholic | 1 |
56 | endotrophic | 2 |
57 | epilepsy-induced | 1 |
58 | extramembranous | 1 |
59 | fetal-first | 5 |
60 | ficat-arlet | 1 |
61 | follicle/oocyte | 1 |
62 | fourth-instar | 4 |
63 | fruitlet | 5 |
64 | fs-driven | 1 |
65 | gal-1-induced | 2 |
66 | gastrula | 9 |
67 | gender-preferential | 1 |
68 | gjb2/gjb6 | 1 |
69 | gnrh-gfp | 1 |
70 | group-operative | 1 |
71 | growing-furring | 2 |
72 | hamilt | 2 |
73 | hepatocytescaused | 1 |
74 | hip-core | 3 |
75 | hitchcock | 2 |
76 | homosynaptic | 5 |
77 | hormone-modulated | 1 |
78 | ifn-alpha-induced | 1 |
79 | ifn-induced | 22 |
80 | ifn-α-associated | 1 |
81 | ifn-α-induced | 12 |
82 | il1-rn | 1 |
83 | interferon-associated | 1 |
84 | interview-defined | 1 |
85 | iodine-enriched | 1 |
86 | jointing | 1 |
87 | kory | 1 |
88 | larval | 462 |
89 | lfcinb-mediated | 1 |
90 | lt-sensitive | 1 |
91 | malignant-related | 1 |
92 | maturating | 2 |
93 | met-min | 2 |
94 | methyl-glyoxal-mediated | 1 |
95 | metoestrous | 2 |
96 | mid-catch-up | 3 |
97 | middle-and-late | 2 |
98 | midsubjective | 1 |
99 | milky | 16 |
100 | mn0.5ni0.1zn0.4nd | 1 |
101 | moder-ate | 1 |
102 | mono-follicular | 3 |
103 | montgomery-asperg | 1 |
104 | myomere | 2 |
105 | namg3 | 1 |
106 | nauplius | 2 |
107 | nematocyte | 2 |
108 | neurointellectual | 1 |
109 | neurula | 2 |
110 | no/transient | 2 |
111 | non-treatment-resistant | 1 |
112 | nonsilent | 2 |
113 | normocarbic | 2 |
114 | nymphal | 11 |
115 | off-color | 1 |
116 | one-cell | 15 |
117 | outbreeding | 1 |
118 | over-wintering | 2 |
119 | oxalate/citrate | 2 |
120 | paranoiac | 3 |
121 | peadiatr | 1 |
122 | peg-ifn-α/rbv-associated | 1 |
123 | peri-adolescent | 3 |
124 | peri-implantation | 21 |
125 | peri-implantational | 2 |
126 | peri-pubertal | 4 |
127 | perithecia | 1 |
128 | pex-glaucoma | 1 |
129 | phytoceutical | 1 |
130 | pliance | 1 |
131 | pon1-55 | 3 |
132 | pospartum | 2 |
133 | post-breeding | 5 |
134 | post-diapause | 2 |
135 | post-hatching | 19 |
136 | post-hematopoietic | 1 |
137 | post-mitotic | 4 |
138 | post-natal | 156 |
139 | post-partial | 1 |
140 | postembryonic | 6 |
141 | postentry | 4 |
142 | postmolt | 7 |
143 | postnatal | 3,521 |
144 | postovulatory | 13 |
145 | postpacing | 5 |
146 | postpartal | 21 |
147 | postpartum/puerperal | 1 |
148 | postpenetration | 1 |
149 | postperinatal | 1 |
150 | postphacoemulsification | 1 |
151 | posturo-motor | 1 |
152 | postwithdrawal | 9 |
153 | pre-hemi-fontan | 2 |
154 | pre-implantation | 67 |
155 | pre-somite | 1 |
156 | pre-to-post-test | 1 |
157 | pre-tumor | 2 |
158 | predispositional | 1 |
159 | preembryonic | 1 |
160 | pregnane | 55 |
161 | preimplantation | 166 |
162 | preleptotene | 4 |
163 | pubertal | 333 |
164 | pupal | 38 |
165 | purebred-crossbred | 1 |
166 | rate-of-force | 1 |
167 | rcoo | 1 |
168 | reconvalesce | 1 |
169 | saponin-supplemented | 1 |
170 | sc-ca1 | 1 |
171 | secondary-geriatric | 1 |
172 | sensory-developmental | 1 |
173 | sm22-rtta | 2 |
174 | sporangiophore | 1 |
175 | sporogonic | 3 |
176 | staff-assisted | 4 |
177 | stron | 1 |
178 | studies- | 2 |
179 | sub-classifying | 1 |
180 | subhyoid | 1 |
181 | surveys.the | 1 |
182 | switch-to | 1 |
183 | tadpole | 25 |
184 | tau-expressing | 3 |
185 | taxane/platinum | 1 |
186 | techno-scientific | 1 |
187 | temporal-dependent | 1 |
188 | term-infant | 1 |
189 | third-instar | 7 |
190 | third-stage | 25 |
191 | tibial-head | 1 |
192 | tioso4 | 1 |
193 | treatment-resistant/chronic | 1 |
194 | treg-cell | 4 |
195 | triassic-arly | 1 |
196 | trigeminothalamic | 2 |
197 | trophont/protomont | 1 |
198 | tumor-nude | 1 |
199 | two-cell | 27 |
200 | txp | 5 |
201 | ulcer/charcot | 1 |
202 | vermiform | 7 |
203 | vitellogenic | 3 |
204 | women-that | 1 |
205 | y=298.28-0.691 | 1 |
206 | ywhae-fam22a/b | 1 |
207 | zoeal | 6 |
1 | studies- | 2 |
2 | 260-370 | 1 |
3 | bos-1 | 1 |
4 | y=298.28-0.691 | 1 |
5 | sc-ca1 | 1 |
6 | 45+/-22 | 1 |
7 | dbp+1/3 | 1 |
8 | namg3 | 1 |
9 | 220.9±7.4 | 1 |
10 | tioso4 | 1 |
11 | 31+/-2.15 | 1 |
12 | 1.100-1.225 | 1 |
13 | pon1-55 | 3 |
14 | 7.08+/-2.36 | 1 |
15 | 5.29+/-2.46 | 1 |
16 | gjb2/gjb6 | 1 |
17 | day-7 | 10 |
18 | 424+/-207 | 1 |
19 | 341,998 | 2 |
20 | 910529 | 1 |
21 | perithecia | 1 |
22 | gastrula | 9 |
23 | neurula | 2 |
24 | pex-glaucoma | 1 |
25 | atheroroma | 1 |
26 | sm22-rtta | 2 |
27 | ywhae-fam22a/b | 1 |
28 | 0.06'c | 1 |
29 | paranoiac | 3 |
30 | normocarbic | 2 |
31 | techno-scientific | 1 |
32 | endotrophic | 2 |
33 | endogenous/melancholic | 1 |
34 | trigeminothalamic | 2 |
35 | apathetic-adynamic | 1 |
36 | vitellogenic | 3 |
37 | sporogonic | 3 |
38 | treatment-resistant/chronic | 1 |
39 | embryonic | 1,006 |
40 | preembryonic | 1 |
41 | postembryonic | 6 |
42 | secondary-geriatric | 1 |
43 | post-hematopoietic | 1 |
44 | post-mitotic | 4 |
45 | homosynaptic | 5 |
46 | tibial-head | 1 |
47 | dssi/sad | 1 |
48 | gal-1-induced | 2 |
49 | ifn-alpha-induced | 1 |
50 | ifn-induced | 22 |
51 | bed-rest-induced | 1 |
52 | epilepsy-induced | 1 |
53 | ifn-α-induced | 12 |
54 | 'retarded | 1 |
55 | iodine-enriched | 1 |
56 | interview-defined | 1 |
57 | purebred-crossbred | 1 |
58 | hepatocytescaused | 1 |
59 | bcl-2-associated | 30 |
60 | interferon-associated | 1 |
61 | peg-ifn-α/rbv-associated | 1 |
62 | ifn-α-associated | 1 |
63 | bcl‑2‑associated | 4 |
64 | lfcinb-mediated | 1 |
65 | methyl-glyoxal-mediated | 1 |
66 | malignant-related | 1 |
67 | hormone-modulated | 1 |
68 | saponin-supplemented | 1 |
69 | staff-assisted | 4 |
70 | cormorbid | 1 |
71 | subhyoid | 1 |
72 | mn0.5ni0.1zn0.4nd | 1 |
73 | anxietyand | 1 |
74 | 50-word | 1 |
75 | pliance | 1 |
76 | rate-of-force | 1 |
77 | reconvalesce | 1 |
78 | tumor-nude | 1 |
79 | third-stage | 25 |
80 | surveys.the | 1 |
81 | tadpole | 25 |
82 | pregnane | 55 |
83 | preleptotene | 4 |
84 | broomrape | 1 |
85 | myomere | 2 |
86 | hip-core | 3 |
87 | sporangiophore | 1 |
88 | post-diapause | 2 |
89 | moder-ate | 1 |
90 | middle-and-late | 2 |
91 | oxalate/citrate | 2 |
92 | disease-state | 3 |
93 | pre-somite | 1 |
94 | follicle/oocyte | 1 |
95 | nematocyte | 2 |
96 | group-operative | 1 |
97 | midsubjective | 1 |
98 | lt-sensitive | 1 |
99 | postpacing | 5 |
100 | post-breeding | 5 |
101 | outbreeding | 1 |
102 | post-hatching | 19 |
103 | 'overcoming | 1 |
104 | over-wintering | 2 |
105 | growing-furring | 2 |
106 | tau-expressing | 3 |
107 | maturating | 2 |
108 | jointing | 1 |
109 | ea-resisting | 1 |
110 | sub-classifying | 1 |
111 | anxious-somatizing | 2 |
112 | montgomery-asperg | 1 |
113 | carbopack | 3 |
114 | /beck | 1 |
115 | hitchcock | 2 |
116 | borderline/clinical | 3 |
117 | phytoceutical | 1 |
118 | zoeal | 6 |
119 | nymphal | 11 |
120 | gender-preferential | 1 |
121 | post-partial | 1 |
122 | peri-implantational | 2 |
123 | predispositional | 1 |
124 | pupal | 38 |
125 | postpartum/puerperal | 1 |
126 | post-natal | 156 |
127 | postperinatal | 1 |
128 | postnatal | 3,521 |
129 | 'postnatal | 5 |
130 | embryo-fetal | 6 |
131 | embryo/fetal | 2 |
132 | embryo/placental | 2 |
133 | sensory-developmental | 1 |
134 | postpartal | 21 |
135 | pubertal | 333 |
136 | peri-pubertal | 4 |
137 | neurointellectual | 1 |
138 | larval | 462 |
139 | postwithdrawal | 9 |
140 | 2-cell | 27 |
141 | 4-cell | 20 |
142 | 16-cell | 7 |
143 | 8-cell | 13 |
144 | one-cell | 15 |
145 | treg-cell | 4 |
146 | two-cell | 27 |
147 | eight-cell | 16 |
148 | /long-term | 1 |
149 | vermiform | 7 |
150 | taxane/platinum | 1 |
151 | pospartum | 2 |
152 | pre-hemi-fontan | 2 |
153 | fs-driven | 1 |
154 | met-min | 2 |
155 | postphacoemulsification | 1 |
156 | postpenetration | 1 |
157 | pre-implantation | 67 |
158 | peri-implantation | 21 |
159 | preimplantation | 166 |
160 | stron | 1 |
161 | il1-rn | 1 |
162 | rcoo | 1 |
163 | switch-to | 1 |
164 | gnrh-gfp | 1 |
165 | mid-catch-up | 3 |
166 | txp | 5 |
167 | 300-year | 1 |
168 | bi-follicular | 3 |
169 | mono-follicular | 3 |
170 | third-instar | 7 |
171 | fourth-instar | 4 |
172 | end-of-semester | 2 |
173 | anxiety/or | 1 |
174 | off-color | 1 |
175 | pre-tumor | 2 |
176 | posturo-motor | 1 |
177 | peadiatr | 1 |
178 | cardiomyopathies-besides | 1 |
179 | nauplius | 2 |
180 | chondro-osseous | 1 |
181 | extramembranous | 1 |
182 | cadaverous | 1 |
183 | metoestrous | 2 |
184 | women-that | 1 |
185 | drug/product | 1 |
186 | ficat-arlet | 1 |
187 | fruitlet | 5 |
188 | hamilt | 2 |
189 | postmolt | 7 |
190 | term-infant | 1 |
191 | antidepressant-resistant | 2 |
192 | non-treatment-resistant | 1 |
193 | peri-adolescent | 3 |
194 | temporal-dependent | 1 |
195 | no/transient | 2 |
196 | nonsilent | 2 |
197 | trophont/protomont | 1 |
198 | ulcer/charcot | 1 |
199 | atropine/breakfast | 1 |
200 | pre-to-post-test | 1 |
201 | fetal-first | 5 |
202 | broad-complex | 1 |
203 | milky | 16 |
204 | triassic-arly | 1 |
205 | kory | 1 |
206 | postovulatory | 13 |
207 | postentry | 4 |